FDA Advisory Panel Recommends Approval Of Single-Dose Tafenoquine For Prevention Of Relapse Of Malaria.
July 13, 2018
MedPage Today (7/12, Walker) reports the Food and Drug Administration’s Antimicrobial Drugs Advisory Committee voted unanimously “to recommend approval of” GlaxoSmithKline’s single-dose tafenoquine “in patients 16 and older for the ‘radical cure’ (preven...